All Stories

  1. No neurodevelopmental benefit of cerebral oximetry in the first randomised trial (SafeBoosC II) in preterm infants during the first days of life

    Article • Acta Paediatrica, July 2018, Wiley

    Frank van Bel

  2. Early Prediction of Hypoxic-Ischemic Brain Injury by a New Panel of Biomarkers in a Population of Term Newborns

    Article • Oxidative Medicine and Cellular Longevity, June 2018, Hindawi Publishing Corporation

    Frank van Bel, Floris Groenendaal

  3. Allopurinol: Old Drug, New Indication in Neonates?

    Article • Current Pharmaceutical Design, February 2018, Bentham Science Publishers

    Dimitrios Konstantelos, Frank van Bel

  4. Repair of neonatal brain injury: bringing stem cell-based therapy into clinical practice

    Article • Developmental Medicine & Child Neurology, August 2017, Wiley

    Frank van Bel

  5. Predictive Role of F2-Isoprostanes as Biomarkers for Brain Damage after Neonatal Surgery

    Article • Disease Markers, January 2017, Hindawi Publishing Corporation

    Frank van Bel, Floris Groenendaal